Rogers Communications Inc... (RCI)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 27 |
Market Cap | 15.30B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 2.24 |
PE Ratio (ttm) | 12.44 |
Forward PE | n/a |
Analyst | Hold |
Ask | 29 |
Volume | 393,665 |
Avg. Volume (20D) | 1,203,547 |
Open | 28.18 |
Previous Close | 28.03 |
Day's Range | 27.87 - 28.18 |
52-Week Range | 26.57 - 45.93 |
Beta | undefined |
About RCI
Rogers Communications Inc. operates as a communications and media company in Canada. It operates through three segments: Wireless, Cable, and Media. The company offers mobile Internet access, wireless voice and enhanced voice, device and accessory financing, wireless home phone, device protection, e-mail, global voice and data roaming, bridging landline, machine-to-machine and Internet of Things solutions, and advanced wireless solutions for busi...
Analyst Forecast
According to 4 analyst ratings, the average rating for RCI stock is "Hold." The 12-month stock price forecast is $70, which is an increase of 151.17% from the latest price.
Next Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
Why Price Moved
News

2 weeks ago · seekingalpha.com
Rogers Communications Inc. (RCI) Q4 2024 Earnings Call TranscriptRogers Communications Inc. (NYSE:RCI ) Q4 2024 Earnings Conference Call January 30, 2025 8:00 AM ET Company Participants Paul Carpino - Vice President, Investor Relations Tony Staffieri - President & ...